221 related articles for article (PubMed ID: 2864260)
1. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
Breese GR; Mueller RA
Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260
[TBL] [Abstract][Full Text] [Related]
2. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
3. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
4. Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
Breese GR; Baumeister A; Napier TC; Frye GD; Mueller RA
J Pharmacol Exp Ther; 1985 Nov; 235(2):287-95. PubMed ID: 3932640
[TBL] [Abstract][Full Text] [Related]
5. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
Jackson DM; Mohell N; Bengtsson A; Malmberg A
Eur J Pharmacol; 1995 Aug; 282(1-3):137-44. PubMed ID: 7498268
[TBL] [Abstract][Full Text] [Related]
6. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
Rubinstein M; Gershanik O; Stefano FJ
Eur J Pharmacol; 1988 Apr; 148(3):419-26. PubMed ID: 2968273
[TBL] [Abstract][Full Text] [Related]
7. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
Hu XT; Wachtel SR; Galloway MP; White FJ
J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
Zarrindast MR; Eliassi A
Gen Pharmacol; 1991; 22(6):1027-31. PubMed ID: 1687393
[TBL] [Abstract][Full Text] [Related]
9. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
10. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.
Ross SB; Jackson DM; Wallis EM; Edwards SR
Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):512-8. PubMed ID: 3261844
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972
[TBL] [Abstract][Full Text] [Related]
12. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.
Starr MS; Starr BS
Pharmacol Biochem Behav; 1989 May; 33(1):41-4. PubMed ID: 2571171
[TBL] [Abstract][Full Text] [Related]
13. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
[TBL] [Abstract][Full Text] [Related]
14. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
15. Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.
Arnt J; Hyttel J
Psychopharmacology (Berl); 1985; 85(3):346-52. PubMed ID: 2860689
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions.
Barone P; Davis TA; Braun AR; Chase TN
Eur J Pharmacol; 1986 Apr; 123(1):109-14. PubMed ID: 2872071
[TBL] [Abstract][Full Text] [Related]
17. Selective protection from the inhibition by EEDQ of D1 and D2 dopamine agonist-induced rotational behavior in mice.
Goodale DB; Jacobi AG; Seyfried DM; Weiss B
Pharmacol Biochem Behav; 1988 Jun; 30(2):457-62. PubMed ID: 2902647
[TBL] [Abstract][Full Text] [Related]
18. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
Carlson JH; Bergstrom DA; Demo SD; Walters JR
Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
[TBL] [Abstract][Full Text] [Related]
19. Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo and supersensitive mice.
Rubinstein M; Schinder AF; Gershanik O; Stefano FJ
Life Sci; 1989; 44(5):337-46. PubMed ID: 2536881
[TBL] [Abstract][Full Text] [Related]
20. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]